Home » Posts tagged 'medical contract manufacturing'
Tag Archives: medical contract manufacturing
Intellectual property (IP) is the core of competitive advantage. When products are outsourced, the contract manufacturer performing the final assembly typically has access to the complete documentation package for the products they build. Where are the checks and balances? How can be certain your company’s IP will be protected? In this whitepaper, Forefront Medical Technology, a specialty contract manufacturer with a focus in disposable diagnostic, drug delivery systems and medical device systems, looks at four areas sourcing teams should audit in determining the ability of their contract manufacturer to support their IP protection needs.
- Company business model
- Supply chain management/documentation control practices
- Level of vertical integration
- Legal protections within the contract manufacturers headquarters’ country.
Read the full whitepaper here.
Regulatory changes can have significant impact on product design and market competitiveness. One upcoming example of this impact is the expansion of the European Union’s (EU) list of Restricted or Hazardous Substances, commonly referred to as RoHS 3. The phthalates added to the list are driving a switch from polyvinyl chloride (PVC) to polyurethane (PU) in medical products including tubing, catheters and bags. As with other RoHS directives, regions outside the EU have followed suit in legislation that restricts these substances. And, economies of scale considerations ultimately drive medical device manufacturers to alternatives which are not restricted in any market. Forefront Medical Technology’s latest whitepaper looks at the implications of this legislation and ways a contract manufacturing partner can assist in the effort to fully evaluate the range of acceptable alternatives, the cost impact of a change, and efficient development and commercialization of products utilizing the chosen alternative materials. Read the full paper here.
Forefront Medical Technology will be exhibiting at MD&M West at the Anaheim Convention Center on Feb. 5-7. Click here and use code SPECIALFOR406 to register for a free pass to the exhibits and a 20% discount on the conference price.
Regionalized outsourcing strategies continue to grow in popularity. Gone are the days of shifting outsourcing to the lowest cost emerging market location. Today, most companies base sourcing strategies on a complex equation of factors driving total cost. When all these factors are considered, locating manufacturing within regions close to each end market often results in the greatest degree of responsiveness to market demand and lowest total cost. The underlying logic behind any regionalization strategy is that proximity to the end market reduces logistics costs and complexity; reduces raw material and finished goods shipping time; decreases finished goods safety stock requirements; and contributes to superior quality by minimizing unnecessary handling, transport and inspections. The question becomes: can the contract manufacturer your company selects enable your company to leverage the benefits of a regionalization strategy in your chosen end markets?
In this whitepaper, Forefront Medical Technology, a specialty contract manufacturer with a focus in disposable diagnostic, drug delivery systems and medical device systems highlights several areas to evaluate in determining whether or not a supplier’s capabilities are likely to deliver lowest total cost of ownership (TCO). Read the full paper here.